Eli Lilly and Co (LLY)
732.20
-13.49
(-1.81%)
USD |
NYSE |
Apr 24, 16:00
727.50
-4.70
(-0.64%)
Pre-Market: 08:11
Eli Lilly Profit Margin (Quarterly): 23.41% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 23.41% |
| September 30, 2023 | -0.60% |
| June 30, 2023 | 21.21% |
| March 31, 2023 | 19.32% |
| December 31, 2022 | 26.54% |
| September 30, 2022 | 20.91% |
| June 30, 2022 | 14.68% |
| March 31, 2022 | 24.36% |
| December 31, 2021 | 21.58% |
| September 30, 2021 | 16.39% |
| June 30, 2021 | 20.63% |
| March 31, 2021 | 19.91% |
| December 31, 2020 | 28.45% |
| September 30, 2020 | 21.05% |
| June 30, 2020 | 25.68% |
| March 31, 2020 | 24.86% |
| December 31, 2019 | 24.46% |
| September 30, 2019 | 22.90% |
| June 30, 2019 | 23.55% |
| March 31, 2019 | 83.30% |
| December 31, 2018 | 19.96% |
| September 30, 2018 | 21.66% |
| June 30, 2018 | -4.65% |
| March 31, 2018 | 24.53% |
| December 31, 2017 | -50.78% |
| Date | Value |
|---|---|
| September 30, 2017 | 9.82% |
| June 30, 2017 | 17.31% |
| March 31, 2017 | -2.12% |
| December 31, 2016 | 13.40% |
| September 30, 2016 | 14.99% |
| June 30, 2016 | 13.83% |
| March 31, 2016 | 9.05% |
| December 31, 2015 | 8.90% |
| September 30, 2015 | 16.12% |
| June 30, 2015 | 12.07% |
| March 31, 2015 | 11.40% |
| December 31, 2014 | 8.37% |
| September 30, 2014 | 10.27% |
| June 30, 2014 | 14.86% |
| March 31, 2014 | 15.54% |
| December 31, 2013 | 12.52% |
| September 30, 2013 | 20.84% |
| June 30, 2013 | 20.34% |
| March 31, 2013 | 27.63% |
| December 31, 2012 | 13.89% |
| September 30, 2012 | 24.37% |
| June 30, 2012 | 16.49% |
| March 31, 2012 | 18.05% |
| December 31, 2011 | 14.19% |
| September 30, 2011 | 20.11% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-0.60%
Minimum
Sep 2023
28.45%
Maximum
Dec 2020
21.01%
Average
21.58%
Median
Dec 2021
Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 9.36% |
| Biogen Inc | 10.46% |
| Madrigal Pharmaceuticals Inc | -- |
| Vertex Pharmaceuticals Inc | 38.48% |
| Viking Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 47.30% |
| Return on Assets | 9.38% |
| Return on Invested Capital | 16.93% |
| Gross Profit Margin (Quarterly) | 80.88% |
| Operating Margin (Quarterly) | 37.85% |
| Return on Net Operating Assets | 13.50% |